Applied DNA Sciences (APDN) Misses Q3 EPS by 24c
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
NET LOSS FROM OPERATIONS: -2.41M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.46), $0.24 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $3.13 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Dexcom names former Stryker CFO Glenn Boehnlein to its board
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
